Omega Healthcare Investors Files 8-K

TL;DR

OHI filed an 8-K, likely containing important updates. Check for details.

AI Summary

Omega Healthcare Investors, Inc. filed an 8-K on June 3, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or operational details in the provided text, but serves as a notification of these items.

Why It Matters

This filing indicates that Omega Healthcare Investors, Inc. is providing updates or disclosures required by the SEC, which could contain important information for investors.

Risk Assessment

Risk Level: low — The filing is a standard SEC disclosure and does not inherently present new risks, but the content of the disclosure itself could be material.

Key Players & Entities

• Omega Healthcare Investors, Inc. (company) — Registrant
• June 3, 2024 (date) — Date of earliest event reported
• Maryland (jurisdiction) — State of incorporation
• 303 International Circle, Suite 200 (address) — Principal executive offices
• Hunt Valley (location) — City of principal executive offices
• 21030 (zip_code) — Zip code of principal executive offices
• 410-427-1700 (phone_number) — Registrant's telephone number

FAQ

From the Filing

0001104659-24-067494.txt : 20240603 0001104659-24-067494.hdr.sgml : 20240603 20240603081526 ACCESSION NUMBER: 0001104659-24-067494 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240603 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240603 DATE AS OF CHANGE: 20240603 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMEGA HEALTHCARE INVESTORS INC CENTRAL INDEX KEY: 0000888491 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] ORGANIZATION NAME: 05 Real Estate & Construction IRS NUMBER: 383041398 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11316 FILM NUMBER: 241012060 BUSINESS ADDRESS: STREET 1: 303 INTERNATIONAL CIRCLE, STREET 2: SUITE 200 CITY: HUNT VALLEY STATE: MD ZIP: 21030 BUSINESS PHONE: 410-427-1700 MAIL ADDRESS: STREET 1: 303 INTERNATIONAL CIRCLE, STREET 2: SUITE 200 CITY: HUNT VALLEY STATE: MD ZIP: 21030 8-K 1 tm2416193d1_8k.htm FORM 8-K false 0000888491 0000888491 2024-06-03 2024-06-03 iso4217:USD xbrli:shares iso4217:USD xbrli:shares     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549       FORM 8-K       CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934     Date of Report (Date of earliest event reported): June 3, 2024   OMEGA HEALTHCARE INVESTORS, INC. (Exact name of registrant as specified in its charter)   Maryland 1-11316 38-3041398 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)   303 International Circle, Suite 200 Hunt Valley , Maryland 21030 (Address of principal executive offices / Zip Code)   ( 410 ) 427-1700 (Registrant’s telephone number, including area code)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:     ¨ Written communications pursuant to Rule 425 under the Securities Act.     ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act.     ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.     ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.   Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:       Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $.10 par value OHI New York Stock Exchange   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company  ¨   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨           Item 7.01 Regulation FD Disclosure.   On June 3, 2024, Omega Healthcare Investors, Inc. (“Omega” or the “Company”) issued a press release providing an update on the restructuring of one of its operators, LaVie Care Centers and announcing that Omega had posted to its website, www.omegehealthcare.com, under the Investor Relations section and under the News & Events section, an updated investor presentation that includes a revised Operator Updates slide on page 10 of the presentation. The updated investor presentation is titled “June 2024 Investor Presentation” and will remain on the Company’s website for a period